Whether the salmon industry can continue to reap the rewards of its recent programme of huge investments is set to be one of the subjects covered in an illuminating presentation by Kolbjørn Giskeødegård on 29 May.
In this two-part feature, The Fish Site and Mike Selden, CEO of the cell-based fish company Finless Foods, discuss the background of lab-grown fish and the origins of Finless Foods bluefin tuna.
Mowi farm technician Clara McGhee discusses the main fish health challenges facing Scottish salmon farmers, the range of methods used to resolve them and some of the gross misconceptions surrounding the sector.
